A former Wells Fargo & Company (NYSE:WFC) Advisors broker in Chico, California, has been permanently barred from the industry for stealing almost $89,000 from an elderly customer, the U.S. securities industry’s principal regulator of brokers said on Monday. Wells Fargo & Company (NYSE:WFC) in last trading activity increased 0.96% to close at $54.97. Company weekly performance is 3.35% while its quarterly performance stands at 6.20%. Wells Fargo & Company (NYSE:WFC) is -0.81% away from its 52 week high.
Shares of Cemex SAB de CV (NYSE:CX) were the recipient of a significant increase in short interest during the month of November. As of November 28th, there was short interest totalling 112,023,234 shares, an increase of 2.9% from the November 14th total of 108,904,531 shares, American Banking News.com reports. On last trading day CEMEX, S.A.B. de C.V. (NYSE:CX) fell -1.03% to close at $10.57. Its volatility for the week is 4.05% while volatility for the month is 3.13%. CX’s sales growth for past 5 years was -2.80% and its EPS growth for past 5 years was 32.30%. CEMEX, S.A.B. de C.V. (NYSE:CX) monthly performance is -15.58%.
Ingersoll-Rand plc (NYSE:IR), will release its 2014 fourth-quarter financial results on Friday, January 30, 2015, at 7 a.m. ET. On last trading day Ingersoll-Rand Plc (NYSE:IR) increased 0.31% to close at $64.19. Its volatility for the week is 1.82% while volatility for the month is 1.54%. IR’s sales growth for past 5 years was -1.10% and its EPS growth for past 5 years was 17.50%. Ingersoll-Rand Plc (NYSE:IR) monthly performance is 2.26%.
On December 11, Ogden Air Logistic Complex (ALC) and Elbit Systems of America, LLC, a subsidiary of Elbit Systems Ltd. (NASDAQ:ESLT), recently signed a Public-Private Partnership (PPP) Agreement defining how the two entities will collaborate during prospective contract opportunities to bring the best possible services and solutions to the warfighter. Elbit Systems Ltd. (NASDAQ:ESLT) has 4.70% insider ownership while its institutional ownership stands at 6.60%. In last trading activity company’s stock closed at $57.60.
Bristol-Myers Squibb Co. (NYSE:BMY) said Monday that the U.S. Food and Drug Administration has approved Opdivo, a new treatment for patients with unresectable or metastatic melanoma who no longer respond to other drugs. Bristol-Myers Squibb Company (NYSE:BMY) in last trading activity moved down -0.39% to close at $61.06. Company weekly performance is 4.29% while its quarterly performance stands at 19.89%. Bristol-Myers Squibb Company (NYSE:BMY) is -0.94% away from its 52 week high.